Wang C, Li S, Li Q, Xi H, Li J, Zhu Q
CNS Neurosci Ther. 2025; 31(2):e70243.
PMID: 39953809
PMC: 11829115.
DOI: 10.1111/cns.70243.
Sheng Y, Qiao C, Zhang Z, Shi X, Yang L, Xi R
Adv Sci (Weinh). 2024; 12(3):e2409310.
PMID: 39585774
PMC: 11744582.
DOI: 10.1002/advs.202409310.
Liu Y, Nishiura M, Fujii M, Sandhu S, Yawaka Y, Yamazaki Y
Cell Commun Signal. 2024; 22(1):561.
PMID: 39578816
PMC: 11583405.
DOI: 10.1186/s12964-024-01945-8.
Prida E, Perez-Lois R, Jacome-Ferrer P, Munoz-Moreno D, Brea-Garcia B, Villalon M
iScience. 2024; 27(11):111120.
PMID: 39498303
PMC: 11533559.
DOI: 10.1016/j.isci.2024.111120.
Matsushige T, Sakabe T, Mochida H, Umekita Y
Cancers (Basel). 2024; 16(17).
PMID: 39272867
PMC: 11394258.
DOI: 10.3390/cancers16173009.
Pyk2 regulates sepsis-induced lung injury via ferroptosis.
Wang J, Bao P, Liu Y
Iran J Basic Med Sci. 2023; 26(11):1283-1290.
PMID: 37886006
PMC: 10598808.
DOI: 10.22038/IJBMS.2023.69578.15153.
Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2.
Liao Y, Remsing Rix L, Li X, Fang B, Izumi V, Welsh E
Cell Chem Biol. 2023; 31(2):284-297.e10.
PMID: 37848034
PMC: 10922442.
DOI: 10.1016/j.chembiol.2023.09.011.
Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Lyu A, Humphrey R, Nam S, Durham T, Hu Z, Arasappan D
Nat Commun. 2023; 14(1):6270.
PMID: 37805579
PMC: 10560206.
DOI: 10.1038/s41467-023-41925-z.
Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
Yadav N, Babu D, Madigubba S, Panigrahi M, Phanithi P
J Neurooncol. 2023; 163(3):675-692.
PMID: 37415005
DOI: 10.1007/s11060-023-04383-7.
Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells.
Li S, Pritchard D, Yu L
Cell Death Dis. 2023; 14(4):268.
PMID: 37055381
PMC: 10102123.
DOI: 10.1038/s41419-023-05789-x.
Physiological and pathological roles of Hic‑5 in several organs (Review).
Yao S, Tu Z, Yang X, Zhang L, Zhong Y, Zheng L
Int J Mol Med. 2022; 50(5).
PMID: 36222304
PMC: 9558762.
DOI: 10.3892/ijmm.2022.5194.
Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca release in cancer cells.
Tangeda V, Lo Y, Babuharisankar A, Chou H, Kuo C, Kao Y
Cell Death Dis. 2022; 13(3):241.
PMID: 35296653
PMC: 8927349.
DOI: 10.1038/s41419-022-04668-1.
Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery.
Zhu T, Yang Q, Shao J, Chen Z, Cai B, Mao G
Virchows Arch. 2021; 479(5):905-917.
PMID: 34313839
DOI: 10.1007/s00428-021-03153-y.
New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer.
Gheysen L, Soumoy L, Trelcat A, Verset L, Journe F, Saussez S
Cells. 2021; 10(5).
PMID: 34063063
PMC: 8147933.
DOI: 10.3390/cells10051112.
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells.
Kitowska K, Gorska-Arcisz M, Antoun D, Zarczynska I, Czaplinska D, Szczepaniak A
Front Oncol. 2021; 11:633410.
PMID: 33898310
PMC: 8059549.
DOI: 10.3389/fonc.2021.633410.
Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells: The Adipokine Receptor CAP1 Matters.
Bergqvist M, Elebro K, Borgquist S, Rosendahl A
Front Oncol. 2021; 11:628653.
PMID: 33738261
PMC: 7962603.
DOI: 10.3389/fonc.2021.628653.
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Tilak M, Holborn J, New L, Lalonde J, Jones N
Int J Mol Sci. 2021; 22(4).
PMID: 33673213
PMC: 7918566.
DOI: 10.3390/ijms22041831.
CCL18 in the Progression of Cancer.
Korbecki J, Olbromski M, Dziegiel P
Int J Mol Sci. 2020; 21(21).
PMID: 33114763
PMC: 7663205.
DOI: 10.3390/ijms21217955.
Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cells.
Chen J, Wang Y, Zhang W, Zhao D, Zhang L, Fan J
Signal Transduct Target Ther. 2020; 5(1):139.
PMID: 32792487
PMC: 7426961.
DOI: 10.1038/s41392-020-0193-z.
Protocadherins at the Crossroad of Signaling Pathways.
Pancho A, Aerts T, Mitsogiannis M, Seuntjens E
Front Mol Neurosci. 2020; 13:117.
PMID: 32694982
PMC: 7339444.
DOI: 10.3389/fnmol.2020.00117.